SGS is exhibiting at PHUSE EU Connect 2021, sharing this online experience by welcoming you to our virtual booth.
Bringing together the global standards community through the event’s innovative, online format, we are pleased to share this virtual experience and welcome you to our virtual booth and presentations. You can also schedule a meeting with our experts.
Don't miss our on-demand presentation 'The Library Approach Driving EDC Set-up Efficiencies: A Case Study' by Project Director, Jan De Cleir at PHUSE EU Connect.
About PHUSE EU Connect
The Connect creates a space for global professionals from across the industry to unite, explore and train through its trademark inspirational content and networking opportunities. As a transition back to physical events, the EU Connect will be a hybrid event, with Monday and Tuesday taking place in person in London, UK (limited capacity) and Thursday and Friday remaining virtual. To enhance the audience experience, a selection of speakers will join PHUSE in London to present in person to both the live audience and virtual attendees as part of the daily broadcast. All sessions will also be available to watch on-demand on the PHUSE Engagement Hub.
SGS is proud to be a sponsor at this event.
SGS Health Science Services
SGS is a leading contract service organization offering clinical research and bioanalytical testing with specific focus on early stage development and biometrics. Delivering solutions in Europe and the Americas, we offer clinical trial (Phase I to IV) services encompassing:
- Clinical project management and monitoring
- Medical writing
- Data management
- Secure data office
- PK/PD data analysis
- Regulatory consultancy
The SGS biometric group is made up of 300 people and organized for flexible allocation to meet the needs of small, medium and large pharma companies. Our EDC team has extensive experience in customized eCRF build, interactive web response systems and electronic clinical outcome assessment. SGS is a CDISC registered solution provider and has successfully submitted full electronic FDA submissions for several candidate drugs.
For further information, please contact:
t: +32 15 27 32 45